50 / 86
Eribulin (Halaven®) Liposarcoma Indication
Eribulin (Halaven®) LPS Indication:
HALAVEN is indicated for the treatment of adult patients
with
unresectable liposarcoma
who have received
prior
anthracycline containing therapy
(unless unsuitable) for
advanced or metastatic disease.
Eribulin (Halaven®) MBC Indication:
HALAVEN is indicated for the treatment of adult patients with
locally advanced or
metastatic breast cancer
who have progressed after at least one chemotherapeutic regimen
for advanced disease. Prior therapy should have included an anthracycline and a taxane in
either the adjuvant or metastatic setting unless patients were not suitable for these
treatments.